SUPERNUS PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2011 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.1M, a 134% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2018 was -$4.27M, a 496% decline from 2017.
  • Supernus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2017 was $1.08M.
  • Supernus Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2016 was -$3.85M, a 38.3% increase from 2015.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.1M +$2.35M +134% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $3.73M +$3.27M +712% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $3.4M -$445K -11.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q3 2023 $1.75M +$672K +62.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $460K +$482K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $3.84M -$8.92M -69.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q3 2022 $1.08M +$4.72M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$22K +$2.86M +99.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $12.8M +$15M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 -$3.64M -$215K -6.27% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$2.88M -$4.54M -273% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$2.29M -$2.31M -10486% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$3.43M -$3.29M -2367% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $1.66M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $22K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q3 2019 -$139K +$965K +87.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q4 2018 -$4.27M -$1.09M -$1.8M -252% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-01
Q3 2018 -$2.46M -$1.1M -$1.67M -294% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q2 2018 -$792K -$1.86M -$2.22M -621% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $1.43M -$212K +$353K +62.5% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $1.08M $716K +$1.46M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$382K $568K +$1.27M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$1.65M $358K +$1.35M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$3M -$565K +$847K +60% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$3.85M -$743K +$72K +8.83% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$3.92M -$703K +$324K +31.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$4.24M -$989K +$193K +16.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$4.44M -$1.41M +$1.8M +56% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$6.23M -$815K -$108K -15.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$6.13M -$1.03M +$608K +37.2% Jul 1, 2015 Sep 30, 2015 10-Q 2017-01-20
Q2 2015 -$6.73M -$1.18M -$628K -113% Apr 1, 2015 Jun 30, 2015 10-Q/A 2017-01-23
Q1 2015 -$6.11M -$3.21M -$1.09M -51.3% Jan 1, 2015 Mar 31, 2015 10-Q/A 2017-01-20
Q4 2014 -$5.02M -$707K +$10.3M +93.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$15.4M -$1.64M +$5.29M +76.4% Jul 1, 2014 Sep 30, 2014 10-Q/A 2017-01-20
Q2 2014 -$20.6M -$554K +$11.3M +95.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$32M -$2.12M -$1.62M -319% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$30.4M -$11M -$10.3M -1339% Oct 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
Q3 2013 -$20.1M -$6.92M -$5.73M -481% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$14.3M -$11.9M -$11.1M -1471% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$3.22M -$506K +$893K +63.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$4.12M -$768K -$347K -82.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$3.77M -$1.19M -$956K -405% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$2.81M -$756K -$212K -39% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$2.6M -$1.4M -$882K -171% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$1.72M -$421K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-21
Q3 2011 -$236K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 -$544K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$517K Jan 1, 2011 Mar 31, 2011 10-Q 2012-06-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.